⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001989905

Anderson Cynthia Lynn

Reports to the SEC for 1 company · SOUTH SAN FRANCISCO, CA

Transactions

6

Companies

1

Filings

6

CIK

0001989905

Forms 4 and 5

Insider transactions

6 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-06-30	VTGNVistagen Therapeutics, Inc.A Award	CHIEF FINANCIAL OFFICER	AAward	+6,617 sh	$1.70	+$11.2K	12,801
2025-06-23	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+100K sh	—	—	100,000
2024-12-31	VTGNVistagen Therapeutics, Inc.A Award	CHIEF FINANCIAL OFFICER	AAward	+2,592 sh	$2.51	+$6,499.44	6,184
2024-06-28	VTGNVistagen Therapeutics, Inc.A Award	CHIEF FINANCIAL OFFICER	AAward	+3,592 sh	$2.96	+$10.6K	3,592
2024-06-24	VTGNVistagen Therapeutics, Inc. · Stock Option (Right to Buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+150K sh	—	—	150,000
2023-08-21	VTGNVistagen Therapeutics, Inc. · Stock Option (right to buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+8,333 sh	—	—	8,333

Recent filings

6

Accepted (ET)
Jul 14
Anderson Cynthia Lynn0001415889-25-018751
SEC(opens sec.gov)
Jun 254
Anderson Cynthia Lynn0001415889-25-018203
SEC(opens sec.gov)
Jan 134
Anderson Cynthia Lynn0001415889-25-001396
SEC(opens sec.gov)
Jul 24
Anderson Cynthia Lynn0001415889-24-019024
SEC(opens sec.gov)
Jun 264
Anderson Cynthia Lynn0001415889-24-018277
SEC(opens sec.gov)
Aug 234
Anderson Cynthia Lynn0001415889-23-012532
SEC(opens sec.gov)

Companies

1

Vistagen Therapeutics, Inc.CHIEF FINANCIAL OFFICERVTGN

Address

C/O VISTAGEN THERAPEUTICS, INC. 343 ALLERTON AVENUE

SOUTH SAN FRANCISCO, CA, 94080